Streptococcal pharyngitis: Is pencillin still the right choice?

Comprehensive Therapy

Volumn 22, Issue 12, 1996, Pages 782-787

  Pichichero, Michael E ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFADROXIL; CEFPODOXIME PROXETIL; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE;

ANTIBIOTIC THERAPY; DRUG CHOICE; DRUG EFFICACY; HUMAN; PHARYNGITIS; REVIEW; STREPTOCOCCUS INFECTION; THROAT CULTURE;

ANTI-BACTERIAL AGENTS; CHILD; HUMANS; PENICILLIN V; PENICILLINS; PHARYNGITIS; PHARYNX; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TREATMENT FAILURE;

EID: 0030459319     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Peter G. Streptococcal pharyngitis: current therapy and criteria for evaluation of new agents. Clin Infect Dis. 1992;14(suppl 2):S218-S223.
2. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr. 1993;123:679-685.
3. Pichichero ME. The rising incidence of penicillin treatment failures in Group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins? Pediatr Infect Dis J. 1991;10 (suppl):S50-S55.
4. Wannamaker LW, Rammelkemp CR Jr., Denny FW, et al. Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with, various amounts of depot penicillin. Am J Med. 1951;10:673-695.
5. Pichichero ME. Explanations and therapies for penicillin failure in streptococcal pharyngitis. Clin Pediatr. 1992;11:642-649.
6. Wannamaker LW, Denny FW, Perry WD, et al. The effect of penicillin prophylaxis on streptococcal disease rates and the carrier state. N Engl J Med. 1953;249:1-7.
7. Breese BB. Treatment of beta hemolytic streptococcic infections in the home: relative value of available methods. JAMA. 1953;152:10-14.
8. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial co-pathogenicity. Pediatr Infect Dis J. 1991;10:275-281.
9. Kaplan EL, Johnson DR. Eradication of Group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J Pediatr. 1988;113:400-403.
10. Brook I. Treatment of patients with acute recurrent tonsillitis due to Group A beta-hemolytic streptococci: a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J Antimicrob Chemother. 1989;24:227-233.
11. Brook I. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984;6:601-607.
12. Pichichero ME. Controversies in the treatment of streptococcal pharyngitis. Am Fam Phys. 1990;42:1567-1576.
13. Brook I, Gober AE. Emergence of beta lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin. Clin Pediatr. 1984;23:338-339.
14. Pichichero ME. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it? Pediatr Infect Dis J. 1993;12:268-274.
15. Randolph MF, Redys JJ, Hibbard EW. Streptococcal pharyngitis. III: streptococcal recurrence rates following therapy with penicillin or with clindamycin (7-chlorolincomycin). Del Med J. 1970;42:87-91.
16. Gooch WM, McLinn SE, Aronovitz GH, et al. Efficacy of cefuroxime axetil suspension compared with penicillin V suspension in children with Group A streptococcal pharyngitis. Antimicrob Agents Chemother. 1993;37:159-163.
17. Block SL, Hedrick JA, Tyler RD. Comparative study of the effectiveness of cefixime and penicillin V for the treatment of streptococcal pharyngitis in children and adolescents. Pediatr Infect Dis J. 1993;11:919-925.
18. Milatovic D, Adam D, Hamilton H, Materman E. Cefproxil versus penicillin V in the treatment of streptococcal tonsillopharyngitis. Antimicrob Agents Chemother. 1993;37:1620-1623.
19. Disney FA, Hanfling MJ, Hausinger SA. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis. Pediatr Infect Dis J. 1992;11(suppl):S20-S26.
20. Pichichero ME, McLinn SE, Gooch WM, et al. Ceftibuten versus penicillin V in Group A beta-hemolytic streptococcal pharyngitis. Pediatr Infect Dis J. 1993;12(suppl):S64-S69.
21. Dajani AS, Kessler S, Mendelson R, Uden DL, Todd WM. Cefpodoxime proxetil vs penicillin V in pediatric pharyngitis/tonsillitis. Pediatr Infect Dis J. 1993;12:275-279.
22. Kolesnichenko TG, Totolyan AA. Distribution of bacteriocin production among group A hemolytic streptococci. Bull Exp Biol Med. 1971;71:661-663.
23. Dajani AS, Tom MC, Law DJ. Viridins, bacteriocins of alpha-hemolytic streptococci: isolation, characterization, and partial purification. Antimicrob Agents Chemother. 1976;9:81-88.
24. Roos K, Grahn E, Holm SE, Johansson H, Lind L. Intefering α-streptococci as a protection against recurrent streptococcal tonsillitis in children. Intern J Pediatr Otorhinolaryngol. 1993;25:141-148.
25. Kucers A, Bennett NM. The Use of Antibiotics. 4th ed. Philadelphia, PA: Lippincott. 1987:3-81, 324-398.
26. Poses RM, Cebul RD, Collins M, Fager SS. The accuracy of experienced physicians' probability estimates for patients with sore throats: implications for decision making. JAMA. 1985;254:925-929.
27. Pichichero ME, Disney FA, Green JL, et al. Comparative reliability of clinical, culture, and antigen detection emthods for the diagnosis of Group A beta-hemolytic streptococcal tonsillopharyngitis. Pediatr Ann. 1992;21:798-805.
28. Lieu TA, Fleisher GR, Schwartz JS. Clinical evaluation of a latex agglutination test for streptococcal pharyngitis: performance and impact on treatment rates. Pediatr Infect Dis J. 1988;7:847-854.
29. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med. 1994;331:377-382.
30. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990;34:2075-2080.
31. Derrick CW Jr., Reilly KM, Stallworth JR. Erythromycin in the treatment of streptococcal infections. Pediatr Infect Dis. 1986;5:172-176.
32. Disney FA, Downton MI, Higgins JE, et al. Comparison of once-daily cefadroxil and four-times-daily erythromycin in Group A streptococcal tonsillopharyngitis. Adv Therapy. 1990;7:312-326.
33. Tanz RR, Shulman ST, Sroka PA, Marubio S, Book I, Yogev R. Lack of influence of beta-lactamase-producing flora on recovery of Group A streptococci after treatment of acute pharyngitis. J Pediatr. 1990;117:859-863.
34. Brook I, Leyva F. The treatment of the carrier state of group A beta-hemolytic streptococci with clindamycin. Chemotherapy. 1981;27:360-367.
35. Milatovic D. Evaluation of cefadroxil penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis. Pediatr Infect Dis J. 1991;10:S61-S63.
36. Portier H, Chavanet P, Gouyon JB, Guetat F. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil. J Antimicrob Chemother. 1990;26:79-85.
37. Pichichero ME, Gooch WM, Rodriguez W, et al. Effective short-course treatment of acute group A beta hemolytic streptococcal tonsillopharyngitis: a comparison of five days vs ten days cefpodoxime proxetil vs ten days penicillin VK in children. Arch Pediatr Adolesc Med. 1994;148:1053-1060.